Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03110822
Title A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncotherapeutics
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.